Skip to content
<title>Channels - Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancer :: FRELIP Discovery
Channels Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancer
Design and synthesis of an erdafitinib-based selective FGFR2 degrader
FGFR Like1 drives esophageal cancer progression via EMT, PI3K/Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis
Molecular aspects of SGLT2 inhibitor interactions in myocardial failure
Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
Use of block inversion in the 2-D interpretation of apparent resistivity data and its comparison with smooth inversion
Structure-guided screening of bioactive phytoconstituents as prospective inhibitors of SARS-CoV-2 M
In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
Bioinformatics Study of Flavonoids From Genus Erythrina As Ace2 inhibitor Candidates For Covid-19 Treatment
Fusion Molecules Between the STAT5b Inhibitor Stafib‐2‐CR and a Cereblon Ligand
Synthesis of fluorinated analogues of oxyresveratrol and their cytotoxic activity against HepG2 and Caco-2 cancer cells
On Marginal Dependencies of the 2 × 2 Kappa
In Silico Discovery of 1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors for Breast Cancer Liver Metastasis via QSAR modeling, Molecular Docking, ADMET, and DFT Studies
Reversal of MPPa‐PDT Resistance in Osteosarcoma by Targeting ROCK2‐Mediated Autophagy
The C2H2‐GGAT Regulatory Module Fine‐Tunes Glutamate Homeostasis to Improve Fruit Flavour and Enhance Disease Resistance in Peach
In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling
Gastric cancer beyond chronic stress
Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Series of Bis-1,2,4-Triazoles as Thymidine Phosphorylase Inhibitor
Open Journal of Cell Biology Vol. 2, No. 2 (June 2012)
Enhancement of immune checkpoint inhibitor efficacy by DHX58+ SELL+ T cells in advanced gastric cancer
[Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report
V. 1, No. 2
V. 2, No. 3
Contents 43(2)
Comparative genomic and resistance characterization of ST2 and ST164 carbapenem-resistant Acinetobacter baumannii from hospital environments and clinical specimens
